The University of Chicago Header Logo

Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.

Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. Oncology (Williston Park). 2003 May; 17(5 Suppl 5):52-5.

View in: PubMed